PLoS ONE (Jan 2015)

Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease.

  • Hyunsuk Kim,
  • Hayne Cho Park,
  • Hyunjin Ryu,
  • Kiwon Kim,
  • Hyo Sang Kim,
  • Kook-Hwan Oh,
  • Su Jong Yu,
  • Jin Wook Chung,
  • Jeong Yeon Cho,
  • Seung Hyup Kim,
  • Hae Il Cheong,
  • Kyubeck Lee,
  • Jong Hoon Park,
  • York Pei,
  • Young-Hwan Hwang,
  • Curie Ahn

DOI
https://doi.org/10.1371/journal.pone.0144526
Journal volume & issue
Vol. 10, no. 12
p. e0144526

Abstract

Read online

Mass effect from polycystic kidney and liver enlargement can result in significant clinical complications and symptoms in autosomal dominant polycystic kidney disease (ADPKD). In this single-center study, we examined the correlation of height-adjusted total liver volume (htTLV) and total kidney volume (htTKV) by CT imaging with hepatic complications (n = 461) and abdominal symptoms (n = 253) in patients with ADPKD. "Mass-effect" complications were assessed by review of medical records and abdominal symptoms, by a standardized research questionnaire. Overall, 91.8% of patients had 4 or more liver cysts on CT scans. Polycystic liver disease (PLD) was classified as none or mild (htTLV < 1,600 mL/m); moderate (1,600 ≤ htTLV <3,200 mL/m); and severe (htTLV ≥ 3,200 mL/m). The prevalence of moderate and severe PLD in our patient cohort was 11.7% (n = 54/461) and 4.8% (n = 22/461), respectively, with a female predominance in both the moderate (61.1%) and severe (95.5%) PLD groups. Pressure-related complications such as leg edema (20.4%), ascites (16.6%), and hernia (3.6%) were common, and patients with moderate to severe PLD exhibited a 6-fold increased risk (compared to no or mild PLD) for these complications in multivariate analysis. Similarly, abdominal symptoms including back pain (58.8%), flank pain (53.1%), abdominal fullness (46.5%), and dyspnea/chest-discomfort (44.3%) were very common, and patients with moderate to severe PLD exhibited a 5-fold increased risk for these symptoms. Moderate to severe PLD is a common and clinically important problem in ~16% of patients with ADPKD who may benefit from referral to specialized centers for further management.